Walnut Creek, CA, United States of America

Edward Lim

This inventor holds 4 USPTO granted patents. Top assignee: Xoma Corporation. Active years: 1997-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward Lim. Retrieved from https://idiyas.com/inventor/edward-lim-flddnefd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1997-2003

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Edward Lim

Introduction

Edward Lim is a notable inventor based in Walnut Creek, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-fungal peptides. With a total of 4 patents to his name, Lim's work has the potential to impact various medical applications.

Latest Patents

Among his latest patents, Lim has focused on anti-fungal peptides derived from Domain III (amino acids 142-169) of bactericidal/permeability-increasing protein (BPI). These inventions relate to both in vivo and in vitro uses of such peptides, showcasing his commitment to advancing medical science.

Career Highlights

Edward Lim is currently associated with Xoma Corporation, where he continues to innovate and develop new solutions in the field of biotechnology. His work at Xoma Corporation has positioned him as a key player in the industry.

Collaborations

Lim has collaborated with notable colleagues such as Roger G Little, II and Mitchell B Fadem, contributing to a dynamic work environment that fosters innovation and creativity.

Conclusion

Edward Lim's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work on anti-fungal peptides demonstrates the potential for significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…